Machine learning discovers new sequences to boost drug delivery
MIT researchers employ machine learning to find powerful peptides that could improve a gene therapy drug for Duchenne muscular dystrophy.
MIT researchers employ machine learning to find powerful peptides that could improve a gene therapy drug for Duchenne muscular dystrophy.
Nearly 300 government and military members participated in a new course designed to explore the next generation of artificial intelligence and related technologies.
Nearly 1,400 joined the AI for Health Care Equity Conference that explored new AI technologies as a platform for change.
A machine learning model developed jointly by Janssen and MIT data scientists played a key role in the clinical trial process for the Johnson & Johnson Covid-19 vaccine.
Using deep convolutional neural networks, researchers devise a system that quickly analyzes wide-field images of patients’ skin in order to more efficiently detect cancer.
Regina Barzilay, Fotini Christia, and Collin Stultz describe how artificial intelligence and machine learning can support fairness, personalization, and inclusiveness in health care.
One of few female students in the 1940s, Wagley was also the Alumni Association’s first female president.
MIT conference illustrates technologies developed in response to the pandemic and new opportunities for AI solutions for clinical management.
MIT Innovation Initiative Venture Builder Luis Soenksen accelerates the launch of unique AI and health care startups in record time.
Research projects will harness the power of artificial intelligence to positively impact human health.
A key part of J-Clinic, the MIT-Takeda Program will create educational opportunities and support cutting-edge research to positively impact human health.
Projects will develop new AI technologies that detect and prevent diseases.
MacArthur “geniuses” in machine learning and synthetic biology to serve as faculty co-leads; Nobel laureate to chair advisory board of new research center.